IFRX
InflaRx N.V.
NASDAQ: IFRX · HEALTHCARE · BIOTECHNOLOGY
$1.98
+18.56% today
Updated 2026-04-29
Market cap
$116.39M
P/E ratio
—
P/S ratio
3,968.21x
EPS (TTM)
$-0.80
Dividend yield
—
52W range
$1 – $2
Volume
0.8M
InflaRx N.V. (IFRX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-4.2%
Last 4 quarters
Revenue YoY growth
+8195.3%
Most recent quarter
EPS YoY growth
-66.7%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+6.3%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+6.8%
2026-03-19
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-19 | $-0.15 | +0.4% | $0.88 | $0.94 | +6.8% |
| 2025-10-30 | $-0.18 | -19.1% | $1.38 | $1.46 | +5.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.15 | $-0.15 | +0.4% | $-35089.00 | +8195.3% |
| 2025-09-30 | $-0.15 | $-0.18 | -19.1% | $23830.00 | -80.8% |
| 2025-06-30 | $-0.17 | $-0.21 | -21.5% | $39432.00 | +520.3% |
| 2025-03-31 | $-0.17 | $-0.13 | +23.5% | — | — |
| 2024-12-31 | $-0.25 | $-0.09 | +64.2% | $-423.00 | -118.9% |
| 2024-09-30 | $-0.25 | $-0.30 | -20.0% | $123819.00 | +103.6% |
| 2024-06-30 | $-0.20 | $-0.24 | -20.0% | $6357.00 | — |
| 2024-03-31 | $-0.22 | $-0.17 | +22.7% | $36037.00 | — |
| 2023-12-31 | $-0.18 | $-0.27 | -50.0% | $2233.00 | — |
| 2023-09-30 | $-0.24 | $-0.13 | +45.8% | $60803.00 | — |
| 2023-06-30 | $-0.31 | $-0.14 | +54.8% | — | — |
| 2023-03-31 | $-0.27 | $-0.25 | +7.4% | — | — |
Frequently asked questions
Has InflaRx N.V. beaten earnings estimates?
InflaRx N.V. has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -4.2% over the last 4 quarters.
How does IFRX stock react to earnings?
IFRX stock has moved an average of +6.3% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is InflaRx N.V.'s revenue growth rate?
InflaRx N.V. reported year-over-year revenue growth of +8195.3% in its most recent quarter, with EPS growing -66.7% year-over-year.